ENST00000457828.6:c.-238G>A
Variant names:
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 1P and 10B. PP3BP6_ModerateBS1BS2
The ENST00000457828.6(LSS):c.-238G>A variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000999 in 1,591,286 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.0012 ( 1 hom., cov: 33)
Exomes 𝑓: 0.00098 ( 3 hom. )
Consequence
LSS
ENST00000457828.6 5_prime_UTR
ENST00000457828.6 5_prime_UTR
Scores
2
Splicing: ADA: 0.9944
2
Clinical Significance
Conservation
PhyloP100: -0.184
Genes affected
LSS (HGNC:6708): (lanosterol synthase) The protein encoded by this gene catalyzes the conversion of (S)-2,3 oxidosqualene to lanosterol. The encoded protein is a member of the terpene cyclase/mutase family and catalyzes the first step in the biosynthesis of cholesterol, steroid hormones, and vitamin D. Alternative splicing results in multiple transcript variants encoding different isoforms.[provided by RefSeq, Feb 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -9 ACMG points.
PP3
Splicing scoreres supports a deletorius effect: Scorers claiming Pathogenic: dbscSNV1_ADA, dbscSNV1_RF. Scorers claiming Uncertain: max_spliceai. No scorers claiming Benign.
BP6
Variant 21-46228611-C-T is Benign according to our data. Variant chr21-46228611-C-T is described in ClinVar as [Benign]. Clinvar id is 1989913.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population amr. gnomad4 allele frequency = 0.00119 (181/152298) while in subpopulation AMR AF= 0.00216 (33/15306). AF 95% confidence interval is 0.00158. There are 1 homozygotes in gnomad4. There are 95 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAdExome4 at 3 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LSS | NM_002340.6 | c.15-12G>A | intron_variant | Intron 1 of 21 | ENST00000397728.8 | NP_002331.3 | ||
LSS | NM_001145437.2 | c.-238G>A | 5_prime_UTR_variant | Exon 1 of 21 | NP_001138909.1 | |||
LSS | NM_001001438.3 | c.15-12G>A | intron_variant | Intron 1 of 22 | NP_001001438.1 | |||
LSS | NM_001145436.2 | c.15-12G>A | intron_variant | Intron 1 of 21 | NP_001138908.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00119 AC: 181AN: 152182Hom.: 1 Cov.: 33
GnomAD3 genomes
AF:
AC:
181
AN:
152182
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00123 AC: 254AN: 205880Hom.: 0 AF XY: 0.00120 AC XY: 138AN XY: 115046
GnomAD3 exomes
AF:
AC:
254
AN:
205880
Hom.:
AF XY:
AC XY:
138
AN XY:
115046
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000978 AC: 1408AN: 1438988Hom.: 3 Cov.: 33 AF XY: 0.000942 AC XY: 674AN XY: 715826
GnomAD4 exome
AF:
AC:
1408
AN:
1438988
Hom.:
Cov.:
33
AF XY:
AC XY:
674
AN XY:
715826
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00119 AC: 181AN: 152298Hom.: 1 Cov.: 33 AF XY: 0.00128 AC XY: 95AN XY: 74482
GnomAD4 genome
AF:
AC:
181
AN:
152298
Hom.:
Cov.:
33
AF XY:
AC XY:
95
AN XY:
74482
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Nov 18, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Pathogenic
dbscSNV1_RF
Pathogenic
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_AL_spliceai
Position offset: -12
Find out detailed SpliceAI scores and Pangolin per-transcript scores at